Abstract. An increasing number of soft tissue filler substances have been introduced to the beauty market outside the U.S. which lack experimental and clinical data in support of their claim. Ten commercially available filler substances were examined for biocompatibility and durability: 0.1 cc of each substance was injected deep intradermally into the volar forearm of one of the authors and observed for clinical reaction and permanence. At 1, 3, 6, and 9 months the test sites were excised, histologically examined, and graded according to foreign body reactions classification. Collagen (Zyplast) was phagocytosed at 6 months and hyaluronic acid (Restylane) at 9 months. PMMA microspheres (Artecoll) had encapsulated with connective tissue, macrophages, and sporadic giant cells. Silicone oil (PMS 350) was clinically inconspicuous but dissipated into the tissue, causing a chronic foreign body reaction. Polylactic acid microspheres (New-Fill) induced a mild inflammatory response and had disappeared clinically at 4 months. Dextran microspheres (Reviderm intra) induced a pronounced foreign body reaction and had disappeared at 6 months. Polymethylacrylate particles (Dermalive) induced the lowest cellular reaction but had disappeared clinically at 6 months. Polyacrylamide (Aquamid) was well tolerated and remained palpable to a lessening degree over the entire testing period. Histologically, it dissipated more slowly and was kept in place through fine fibrous capsules. Polyvinylhydroxide microspheres suspended in acrylamide (Evolution) were well tolerated, slowly diminishing over 9 months. Calcium hydroxylapatite microspheres (Radiance FN) induced almost no foreign body reaction but were absorbed by the skin at 12 months.Host defense mechanisms react differently to the various filler materials, but all substances-resorbable or nonresorbable-appeared to be clinically and histologically safe, although all exhibit undesirable side effects. Since the mechanism of late inflammation or granuloma formation is still unknown, early histological findings are not useful in predicting possible late reactions to filler substances.
In recent decades, dermal filler substances consisting of highly viscous fluids [33, 40, 53] or polymer particle suspensions [21, 37] have been injected beneath wrinkles and acne scars [8, 31] . These substances are useful for the correction of congenital or traumatic facial, bony, and soft tissue defects [10] , and in patients suffering from scleroderma, Romberg's disease, facial wasting, or lipodystrophy following AIDS treatment [2, 11, 57] . Additional indications are unilateral paralysis of vocal cords [12, 24, 28] , augmentation of the lip and soft palate in cleft lip patients, anophthalmic orbits [10] , or enophthalmus. Other potential applications as bulking agents are lower esophageal sphincter in gastroesophageal reflux patients [22, 48] , and bladder neck or anal sphincter in patients suffering from urinary [5] or fecal incontinence [27, 63] .
Animal studies [38] and clinical trials [15, 19] have shown good acceptance and short-and long-term efficacy in accordance with the chemical structure and surface characteristics of the microparticles. Resorbable materials such as collagen, hyaluronic acid [19, 36, 49] , polymethylacrylate (PMA) [6] , dextran [20] , or polylactic acid [2] are removed by phagocytosis over a period of 3-12 months depending on the amount and type of bulking agent implanted. Permanent fillers such as paraffin [33] , fluid silicone [11, 17] , Teflon [34] , or silicone particles [21] have an irregular surface and cannot be phagocytosed but may eventually form foreign body granulomas due to ''frustrated macrophages'' [20] . Microspheres below the size of 15 microns [44, 61] are generally phagocytosed and may be transported to local lymph nodes. Larger microspheres from nonresorbable polymers with a smooth surface [35, 38, 51] are encapsulated with fibrous tissue and escape phagocytosis. Clinically, all injected fluids [45, 59] and particles [54, 56] have been shown to cause foreign body granulomas in a small percentage of patients. Until the mechanism of granuloma formation is fully understood, the chance of development is not predictable.
The ideal soft tissue filler substance for wrinkles, skin defects, and sphincter is biocompatible and safe is stable at the implantation site keeps its volume and remains pliable does not cause protrusion of the skin or mucosa induces minimal foreign body reaction will not be removed by phagocytosis has no migration potential to distant locations does not cause foreign body granuloma.
As a percentage of wet weight, the human skin is composed of collagen (27-39%), elastin (0.2-0.6%), glycosaminoglycans (0.03-0.3%), and 60-72% water. The goal of this study was to confirm histocompatibility and permanence of various filler substances under investigation. For some products there exist no published scientific reports on biocompatibility, histology, or clinical studies.
Materials and Methods
During the past 4 years, four 0.1-cc blebs of 10 different dermal filler substances have been injected deep intradermally into the volar skin of a forearm, next to an existing scar. The injection sites were inspected weekly and clinical changes were recorded and photographed. Each raw of the different implants was excised after 1, 3, 6, or 9 months. At least four sections were cut from each implantation site at different levels for histological examination. The sections were stained with hematoxilin-eosin or Masson trichrome and evaluated in Frankfurt. An independent pathologist (U.C.) was blinded, receiving the histological slices numbered only, and being unaware of the material involved.
A classification of foreign body reactions, established by Duranti et al. [19] , was applied to each histological slide. The grading was performed on at least four slices of the same specimen. 
Results
All four implant sites in the human forearm could easily be identified after 1 and 3 months; however, not all implants could be visualized after 6 and 9 months. In the latter cases, the whole area was excised and sectioned 5-10 times in order to identify microscopic traces of the implant.
Zyplast
The tissue sections obtained from human skin showed the presence of many macrophages and invading capillaries at the circumference of the implants at 1 month. This process goes along with slow resorption of the crosslinked eosinophilic opaque material with gradual and scarce infiltration of inflammatory cells, and little or no deposition of structures, which resemble new collagen fibers at 3 months [32] . At 6 months, no residue of cell-free Zyplast could be found in the human skin. The histological reactions were evaluated according to the Duranti scale (Fig. 1 ).
Restylane
The clear hyaluronic acid gel induced erythema and swelling in the human skin for 2 days. Clinically, Restylane and all other tested crosslinked hyaluronic acid products disappeared from the skin within 4 months. Histologically, the blue stained hyaluronic acid showed little foreign body reaction ( Fig. 2 ) but was slowly degraded by macrophages. Some macrophages and rare giant cells were apparent in the human skin at 3 months [19] . Clusters of these cells could still be found after 6 months; however, no residue could be identified at 9 months.
Artecoll
At 1 month, each individual microsphere was separated from adjacent microspheres by a thin layer of eosinophilic material representing collagen fibers (Fig. 3) . The implants were discrete and well circumscribed within the soft tissue. The peripheral regions of these foci had infiltrated to a depth of 2-3 microspheres and contained macrophages (1 per approximately 15 beads) and few multinucleated giant cells. The centers of the lesions were cell free and separated through fibrin fibers only. At 3 and 6 months, isolated giant cells extended deeper into the lesions (Fig. 4) . The implanted denatured collagen appeared to be resorbed at 3 months. New collagen deposits, evident at 1 month, increased the spaces between individual microspheres. The number of inflammatory cells was small at all times and indicates that collagen and microspheres induce a minimal immunogenic response.
The relative size of the palpable Artecoll lesions in human skin remained unchanged over 9 months (Fig. 5) , suggesting that dissipation of microspheres into the surrounding soft tissue or migration to adjacent lymph nodes does not occur (Fig. 3) .
PMS 350 Silicone Fluid
PMS 350 is a colorless oil with a low viscosity, 350 times that of water (1 centistoke = viscosity of water), but with high chemical stability. Immediately after injection, PMS 350 dispersed into the surrounding tissue in form of millions of microdroplets (Fig. 6) . At 1 month, each microdroplet, about 20-100 microns in size, was encapsulated by a monolayer of fibroblasts and collagen fibers. Macrophages and giant cells, which phagocytosed the foamy, translucent, bifringent material, were found at 3 and 6 months. Asteroid bodies in the cytoplasma of macrophages and giant cells were typically seen after phagocytosis of the silicone fluid. At 9 months, granulomatous nodules in the dermis and subcutaneous tissue were surrounded by strands of fibrous tissue.
New-Fill
The PLA implants were well palpable for the first 3 months but had disappeared from the human skin at 4 months. In the refrigerator, PLA microspheres with diameters between 2 and 50 lm, were still recognizable as microspheres 2 weeks after suspension, and were partly hydrolyzed and deformed at 1 and 3 months.
Histologically, a fine capsule could be observed around the implant throughout. At 3 months, the microspheres had remained spherical and were surrounded by macrophages and some lymphocytes ( Fig. 7) . At 6 months, most microspheres showed a porous surface structure, were fissured and sometimes deformed, and were surrounded by macrophages and small giant cells. Their pseudopodia infiltrated the surface of some microspheres but did not degrade the activity of these cells. The PLA was likely dissolved by hydrolysis and extracellular enzymes [3, 60] and subsequently broken down by macrophages. At 9 months, the degradation of PLA microspheres was completed. At 9 months, no remnant of cicatricial fibrosis was found after total disappearance of PLA residues in the human skin. This finding illustrates the excellent biocompatibility of PLA.
Reviderm intra
The injection of dextran beads caused swelling and redness, which continued for 10 days-possibly due to the toxic effect of free dextranomers. Edematous swelling of the implants continued for more than 3 months. The palpable deep dermal implant began to disappear at 4 months and was no longer palpable at 6 months.
Histologically, the 40-lm dextran beads produced the greatest amount of granulation tissue among all injectables tested. At 1 month, the hydrophilic microspheres were swollen and measured up to 75 lm in diameter (Fig. 8) ; some were broken apart and surrounded by foamy macrophages and small giant cells. The hyaluronic acid carrier had early separated from the beads and was found in pools, surrounded by a rim of giant cells (Fig. 9) . At 3 months, only few elastic fibers could be seen; instead there were great numbers of macrophages and giant cells, which enveloped and tried to phagocytose the beads. The surface of the dextran beads began to show irregularities at 6 months and total disintegration at 9 months. It ranged to the top of the Duranti scale among the resorbable implants ( Fig. 10) , possibly due to the carrier from an undisclosed source of hyaluronic acid (Rofilan), which has been crosslinked with a plant extract.
Dermalive
The hydroxyethyl-methacrylate (HEMA) fragments began to disappear in the human skin at 4 months and were no longer palpable at 6 months.
Histologically, they showed the least cellular reaction of all implants. The polygonal, translucent, and irregular particles, 20-120 lm in size, which appeared like clear broken glass gravel, were packed in clusters, with minimal ingrowth of fibrous tissue, cells, and blood vessels (Fig. 11) . Only a fine network of elastic fibers and occasionally macrophages were found, but there were no apparent capillaries and no strong fibrous capsule. The hyaluronic acid was separated and surrounded by macrophages, which had disappeared at 3 months. At 9 months, only a few small clusters of Dermalive with rounded corners and ridges, many macrophages, and lymphoid cell clusters could be detected. The few giant cells contained abundant asteroid bodies in their cytoplasma. Some pointed particles had a tendency to irritate the surrounding soft tissue, which showed clear evidence of low grade inflammation. However, only about one tenth of the implant volume consisted of cells and fibers (Fig. 11) .
Aquamid
The clear gel of polyacrylamide was implanted into human skin at four sites. Used in breast augmentation in Ukraine and China, it had a viscosity of 1045 centistoke. Since no anesthetic is added, the injections into human skin caused a burning sensation for 20 sec. This was likely due to the cross-linked gel's pH of 7.0 to 9.0. On examination, the implants revealed no reaction and were still palpable at 9 months, but decreasing in size.
Histologically, acrylamide gel was difficult to detect at 1 month. The injected, non stainable transparent gel produced only a fine fibrocellular capsule (Fig.  13) , as expected from the literature [14, 42] . At 3 months, no further histopathological reaction occurred outside the implant site, such as foreign body reaction. At 6 and 9 months, Aquamid had dispersed into the skin and was surrounded by macrophages and fibroblasts (Fig. 12) . The histological reaction resembled that of injected fluid silicone. In small quantities, such as a slim strand beneath a wrinkle, the gel appeared to be slowly absorbed, without visible foreign body reaction. Therefore, the manufacturer's claim of ''lifelong permanence'' seems to be dependent on the amount of implanted acrylamides.
Evolution
Clinically, the implant made of polyvinylhidroxide microspheres suspended in acrylamide gel resembles Artecoll. It was not painful during injection as was Aquamid. Because of evaporation through the polyethylene syringe, the water content of the material was already diminished at the time of purchase. The implants were well visible and diminishing palpably over the whole course of 9 months. Histological examination showed the beads, most of them 30-40 lm in diameter, within the clear acrylamide gel (Fig. 13) surrounded by an almost invisible fibrous capsule. Each droplet, 3-5 mm in size, was encapsulated with a very fine layer of fibroblast and fibers without ingrowth into the implant. No foreign body reaction was detectable. A few single microspheres outside the implant site were covered with a fibrin layer or had attached macrophages and fibroblasts. At 6 and 9 months, most of the carrier gel had been absorbed and was replaced at the outer layers by granulation tissue. At 9 months, the implant was totally infiltrated by macrophages, fibroblasts, and giant cells (Fig. 14) , which resembled the tissue ingrowth of PLA at 3 months. The surface of the microspheres was still intact after 9 months.
Radiance FN
Clinically, the subdermal implants in the forearm were swollen for 3 days. Within 1 month, the palpable implant diminished to half its prior size and became whitish and shining through the skin. The hard nodules diminished further in size and disappeared clinically at 9 months from the skin.
Histologically, Radiance microspheres stimulate almost no foreign body reaction. The 1-month sample had to be embedded in PMMA like bone tissue because the implant could not be cut by conventional methods. The beads were packed and surrounded by some fibrin fibers but little cellular tissue. At 3 months, a method of rapid decalcification was applied prior to cutting and staining. The beads were still packed (Fig. 15) and tissue ingrowth started from the fine outer capsule of the implant. The main ''interstitium'' still consists of fibrin fibers and few cellular elements like fibroblasts and flattened macrophages. No vascularity could be detected. At 6 months, the whole implant is surrounded by a fine fibrous capsule and single microspheres are encapsulated by a thin fibroplastic stroma with flattened cells. At 9 months, the voids are much smaller in diameter and the microspheres deformed and slowly adsorbed (Fig. 16 ). Since few macrophages were seen it is suggested that calcium hydroxylapatite microspheres are degraded by enzymatic breakdown rather than phagocytosis.
Discussion

Collagen Gel
Bovine collagen is the ''gold standard'' for all other newly introduced injectables. To date, Zyderm and Zyplast have been the only FDA-approved dermal filler substances in the U.S. for more than 20 years. The limited longevity of Zyderm and Zyplast, ease of use, low incidence of allergic reactions (<1%), and safety are well established [32] . Late granuloma formation occurs at a lower rate [26, 45] than with slowly resorbable gels and particulate materials.
Hyaluronic Acid Fluids
Human hyaluronic acid, a polysaccharide of 4-5 kDa molecular weight has a half-life of only 1-2 days. It forms the cellular interstitium of the dermis and creates volume by binding water. A human body contains approximately 15 g HA. To avoid an early breakdown, injectable hyaluronic acids have to be crosslinked. The HA in Restylane has a molecular weight of 1 · 10 6 Da, but 0.5% or every 200th amino acid of the molecule is crosslinked (''stabilized'') with a neighbor molecule. The company claims that it contains a suspension of 1 · 10 5 HA particles of 40-60 lm size in HA fluid. A similar product, Perlane, is said to contain 8 · 10 3 gel particles/ml of approximately 100 lm in diameter, and Fine Lines approximately 2 · 10 5 gel particles/ml of 20-30 lm in diameter. These gel particles, however, cannot been seen under the microscope. Residues from the process of fermentation of Streptococcus equi (>107 lg/ml [41] 
PMMA Microspheres
These microspheres showed the most stable appearance throughout the experiment. Once injected, the PMMA microspheres cannot be broken down by enzymes, since a methyl group in the alpha-position stabilizes the molecule. Interestingly, the volume of the injected collagen (80%) remained stable in the implant over the years (Fig. 5) . The microspheres act merely as a scaffold and a stimulus for constant connective tissue production. Here, the implant carrier is truly ''replaced'' by the body's own tissue. In contrast to other ''dead'' permanent filler substances like acrylamide or Radiance, the ingrowth of connective tissue creates a ''living'' implant.
Artecoll gives predictable results; however, at the same time it is ''non-forgiving'' when mistakenly implanted in an incorrect plane. To avoid technical mistakes, introductory courses and a careful learning curve are required. It may induce granuloma formation in very rare instances [35] , as all other substances will do in certain patients. Artecoll has a 10-year history [35] and has been used in more than 200,000 patients worldwide outside the U.S.
Another injectable implant of PMMA microspheres, 1-80 lm in diameter but suspended in Mgcarboxy-gluconate (Metacrill), is produced and distributed in Brazil [47] .
Silicone Fluid
As we know from ruptured breast implants, silicone gel causes the rarest foreign body reaction among the filler materials. In most patients, silicone gel remains very soft and is encapsulated by only a very thin layer of fibroblasts. The lack of fibrous capsule formation may lead to the displacement of larger quantities, aided by gravity, which may migrate downwards from the glabella to the cheeks and from the nasolabial folds to beneath the chin. In time, the implant can harden through ingrowth of connective tissue, macrophages, and foreign body cells, which form a granuloma [53] .
The reputation of ''medical grade'' silicone fluid has been damaged by five facts: (1) the use of large quantities, e.g., in breast augmentation or facial dystrophies [17, 18] , has led to deformation; (2) the possibility of gravity induced ''migration'' in patients with very lax skin and subcutaneous tissue; (3) the possibility of late (5-20 years) granuloma (siliconoma) formation; (4) the substitution of cheaper, non-medical-grade silicone fluids by nonprofessionals; and (5) the lack of experience of most physicians in the treatment of rare cases of late siliconoma. Though difficult to remove surgically, siliconomas respond favorably to multiple injections of corticosteroid [7] or antimitotic agents [58] . The wrinkles and lips of thousands of patients in Europe and Asia have been treated successfully with the micro-droplet technique with small amounts of medical-grade silicone fluid. On the other hand, hundreds of women required total mastectomy due to chronic inflammation of large amounts of silicone oil injected directly into the breast. As so often in medicine, success depends on the right dosage, volume, and knowledge of side effects.
Polylactic Acid Microspheres
Polylactic acids do not occur naturally, but were first synthesized by French chemists in 1954. PLA and polyglycolic acid (PGA) have been used safely in suture materials (Vicryl, Dexon), in resorbable plates and screws, in guided bone regeneration, in orthopedic, neuro-, and cranio-facial surgery, and as drug delivery devices [60] . PLA does not stimulate the natural production of collagen [2] , but causes a foreign body reaction, characterized by macrophages, giant cells, and some elastic fibers. The PLA polymer New-Fill disappeared within 6 months, probably due to extracellular hydrolysis, ester cleavage, and the catalytic effect of hydrosoluble acid monomers formed in the polymer matrix during degradation [3] . Whether the mild inflammatory response elicited by PLA can be ascribed to degradation activity of macrophages is not clear.
The degradation rate of PLA polymers in vivo is said to be almost twice that in vitro [60] . Our experiments with microspheres, however, have shown the opposite. After refrigeration for 6 months, the microspheres in their fluid cellulose carrier had dissolved totally, whereas the microspheres in living tissue were still recognizable as round with irregular surface. The degradation of different PLAs is affected dramatically by the amount of glycolic units in the lactic acid chains [60] . Degradation only appears when the molecular weight of the PLA decreases below 20 · 10 3 Da. The PLA in New-Fill has a molecular weight of 170 · 10 3 Da. Nine months after implantation, no polymer residue or remnant cicatricial fibrosis were found, confirming the good biocompatibility of PLA microspheres. Since PLAs contain no animal proteins, allergies are not expected; however, late granulomas have been reported as with any other filler substance.
Dextran Microspheres
Dextrans are the substrate of chromatography columns (Sephadex) used for the separation of proteins. Dextran molecules of 40,000 and 80,000 Da are used as plasma expanders, since dextran molecules <20,000 Da will be filtered by the kidney. Dextran beads of 100 lm in diameter were found intact 2 years after implantation in the back skin of rats. Eppley et al. [18] emphasized that the positive surface charges of dextran beads apparently attracted macrophages. The macrophages in turn release TGF-beta and interleukins, which stimulate fibroblasts to produce collagen fibers. After extensive resorption of the dextran beads at 9 months, however, little or no cicatricial residue could be detected at the implantation sites in these studies. Dextran beads of 100 lm in diameter (Deflux, Q-Med, Uppsala, Sweden) are currently used in clinical trials for the treatment of stress urinary incontinence.
HEMA Fragments
Dermalive is a by-product of the manufacture of intraocular lenses and was introduced in the European Fig. 17 . Duranti classification reflects the extent of foreign body reaction at certain times. Class 4 defines granuloma formation. Bioplastique is a suspension of silicone particles in PVP. Embosphere are soft microspheres of trisacrylgelatin used for tumor embolization [4] . market in 1998. Because of a rather high incidence of granuloma formation, it is now used mainly in the form of Dermadeep with HEMA fragments 80-110 lm in size for deep dermal and epiperiosteal implantation. Inside the implant, the HEMA particles were packed closely, probably due to diminished viscosity of the carrier medium hyaluronic acid. This carrier dissipated from the particles just after implantation of Dermalive and was found outside of the clusters of particles.
The great advantage of collagen as a suspension medium for filler substances is its high viscosity, which keeps the particles or microspheres apart weeks after implantation. Since little host tissue formation is stimulated, more Dermalive has to be injected compared to other fillers. On the other hand, HEMA has a free OH-group, which should stimulate macrophage activity. Endogenous esterases in serum and liver break down HEMA. Interestingly, the amount of tissue reaction is no indication for the rate of granuloma formation. In the studies described here, Dermalive evoked the least new tissue formation but clinically causes a rather high rate of granuloma formation [54] .
Polyacrylamide Gel
Like dextran beads, polyacrylamide is used mainly for protein separation by molecular biologists. The use of polyacrylamides as injectable filler materials was initiated in 1983, and they were used clinically in the Ukraine and China as Interfall [14] or ''Amazing Gel'' in thousands of patients. However, to date few clinical and scientific data have been published in Western literature [23] . Since Interfall's patent expired, at least seven European companies are marketing polyacrylamides as dermal filler substances (Royamid, Argiform, Bioformacryl, OutLine, Aquamid, Evolution, Kosmogel). So far, they have been injected in large quantities for breast, buttock, and calf augmentation, in facial lipodystrophy and congenital malformations [14] , and have been called ''endoprotheses'' [42] . If overcorrection occurs, the fluid can be withdrawn from the implant even after years. Reportedly, it has a half-life in the human body of >20 years. This may be true for large quantities; however, the injection of 0.1 cc Aquamid was resorbed in human skin within 9 months. The concentration of acrylamide monomers that can be toxic was reported to be <10 ppm or 0.04%. Side effects were enlarged lymphnodes in 10%, migration of gel in 3%, and edema in 2%. The U.S. Environmental Protection Agency classifies acrylamide as a medium-hazard probable human carcinogen. Even if there are few published reports [30] , granuloma formation after Interfall implantation is well known in China since 1997 [14] and has to be expected in certain patients as with all other injectables.
Polyvinyl Gel Microspheres
The mixture of apparently slowly resorbable Polyvinyl microspheres with a longer lasting polyacrylamide gel (Evolution) showed similar histological reactions to Aquamid within the first 6 months, and from then on was like Artecoll. Clinically and histologically it showed the least reactions and remained visible and palpable throughout the 9 months. Future clinical experience has to show whether late side effects are as high as with acrylamides.
Calcium-Hydroxylapatite Microspheres
Ca-hydroxylapatite is the primary component of bone and dents. In form of particles it was first used as onlay grafts for bone regeneration in dentistry. Cahydroxylapatite microspheres of 75-125 lm in diameter (CoaptiteÒ) are injected as a bulking agent in urinary incontinence. It is highly biocompatible, causes little tissue reaction, well defined at the injection site, radio-opaque, and can therefore be used as a tissue marker (Radiance FN). In the skin and especially in the lip, it does not ''remain soft'' but exhibits a clear hardening of the implant, which resolves over time. Since March 2002, Radiance FN can be used ''off-label'' in the US for wrinkle treatment and lip augmentation. Since it disappeared from the skin within 12 months, it is a semi-permanent implant like many others (Aquamid, Dermalive, New-Fill, Reviderm) and not a ''near-permanent solution''. While Radiance is well tolerated beneath wrinkles, it should not be recommended for lip augmentation. The concomitant movement of the orbicularis muscle in women during chewing compresses every injected strand to a lump! Histologically, the calcium hydroxylapatite microspheres do not ''provide a scaffold for tissue infiltration consistent with the form of the surrounding tissue''. Because of little tissue ingrowth [16, 43] and absence of granulation tissue, triamcinolone (KenalogÒ) injections into Radiance lumps will be ineffective and should be omitted. In some patients, however, Radiance microspheres may induce a kind of foreign body reaction -as demonstrated by one histological picture in the company's advertisement, which of course will react to intralesional corticosteroids.
In general, the histological examination of all samples showed distinctive morphological findings for each type of micro-implant, which can help distinguish different injected substances. The differential diagnosis could also be of medico-legal interest because adulterated or improper substances are sometimes injected fraudulently [54] . PMA-particles (Dermalive) showed multiple sharp edges and points taking on a ''broken glass'' appearance, whereas microspheres are devoid of any jagged or sharp edges that might serve as a continued source of irritation.
Complications
Besides well-known allergies, displacement, and granuloma formation, another potential complication of dermal filler substances was documented only recently [62] . Localized fat atrophies in the cheeks, similar to those seen in facial lipodystrophy after HIV treatment [11, 57] , occurred 2-3 months after the implantation of Restylane or New-Fill in the nasolabial folds of healthy patients. At 9 months, the implants could still be identified and were interspersed with giant cells and granulomatous tissue. The residues were encapsulated and surrounded by fat necroses and vacuoles. No explanation has been found for this side effect since there is no obvious link in the chemical structure of these two filler substances and HIV protease inhibitors.
Granulomas
All injectable filler materials cause normal foreignbody-type reactions that may develop into a foreign body granuloma in selected patients. Its cause is still unknown and no predictions can be made. Some of the patients reported a severe generalized viral or bacterial infection [37, 41, 53] , vaccination, or local trauma some months before the appearance of the granulomas.
Granulomas occur in patients at a rate of 0.01% to 1.0% according to the chemical composition, shape, and surface structure of the particles [38] . They occur significantly less often after implantation of microspheres with a smooth surface (Artecoll, New-Fill, Evolution) [37, 38] than after implantation of particles with irregular surface (Bioplastique, Dermalive) [6, 54] . As would be expected, they also occur less frequently after injection of resorbable implants (collagen [29, 45] , hyaluronic acid [13, 25, [39] [40] [41] 59 ]) compared to long-lasting implants [53, 54] .
Legal Aspects
In contrast to the FDA, Notified Bodies of the European Community do not require animal or clinical studies for the registration and approval of injectable filler substances or surgically introduced artificial implants. The European product quality control systems classify injectable dermal fillers as Medical Devices Class IIa (resorbable substances), and Class IIb (substances that cannot be reabsorbed). The FDA has determined that collagen is a Class III.A device and injected particles are a Class III.B device. In November 1997, a new provision was added to the Federal Food, Drug, and Cosmetic Act to allow any legally marketed, FDA-approved product to be administered for any condition within a doctor-patient relationship. This is called ''off-label use'' of an FDAapproved product.
The CE mark controls only Good Manufacturing Practice (GMP) of an injectable agent but does not guarantee a maximum of biological safety. Therefore, a central office similar to the FDA should be established in Europe to which all severe clinical side effects have to be reported. Some manufacturers report the complication rates as a percentage of treatments (Restylane, Hylaform, Dermalive)-most probably of syringes sold-, whereas other manufacturers report the side effects as percentage of treated patients [35] . Only a careful statistical analysis of these data will shed some light on the true incidence of side effects for each dermal filler substance.
Conclusions
The differences in histological reactions and in permanence lead to a classification of injectable filler substances into five types:
1. Autologous fat rarely is permanent and its fate is unpredictable. The mechanism for long-term survival of fat or stem cells has yet to be understood. 2. Natural filler substances such as collagen and hyaluronic acids are phagocytosed slowly with minimal histological reaction. 3. Fluid filler substances, such as fluid silicone and acrylamides, cause little fibrosis but can dislocate larger volumes through muscle movement and gravity; they are considered ''dead implants.'' 4. Particulate materials like PMA gravel and PLA microspheres are packed and induce minimal foreign body reaction and fibrosis. They are pure fillers and are slowly resorbed. 5. Microspheres from non-resorbable PMMA or resorbable dextran are stimulants for encapsulation and scaffolds of permanent or temporary connective tissue formation, considered ''living implants. '' Host defense mechanisms reacted differently to each filler material; however, all substances-resorbable or nonresorbable-appeared to be clinically and histologically safe. None of the tested substances is without undesirable effects [1, 46, 52, 55] . Since the cause of late inflammation or granuloma formation is not yet known, predictions can be not be made from early histological results for possible late reactions of the host to an individual filler substance.
Therefore, materials must be selected according to the needs of the individual patient. The patient should be informed and involved in the choice of resorbable or long-lasting filler substance. Hyaluronic acid and new collagen products such as Cymetra, Fascian, or CosmoDerm could not be demonstrated to last longer than bovine collagen. The development of a possibly disease-and allergy-free human recombinant collagen from yeast (Fibrogen, San Fran-cisco) or cow milk (Cohesion Technologies, Palo Alto) has a long way to go. The search for the perfect permanent injectable material with maximum safety is ongoing. Time and a centralized registry of adverse events-similar to the registries for silicone breast implants-will bring improvement in efficacy and safety of new generation filler substances.
